Related Experiment Video
Updated: Aug 4, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023
David S Ettinger1, Douglas E Wood2, Dara L Aisner3
1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Abstract:
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Standards of Care II
Treatment Resistant Cancers